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Abstract:  Blood lead among pregnant women, even at modest levels, may impair 
offspring cognitive development. We examine whether blood lead levels (BLLs) result 
from current versus historic exposures, among a cohort of pregnant women. Cumulative 
logit models were used to characterize the relationship between maternal risk factors and 
higher BLLs. Maternal blood lead levels more likely result from lead remobilization from 
historic  versus contemporaneous exposures. Even if all lead sources were abated 
immediately, women and their fetuses would experience lead exposure for decades. This 
work emphasizes the importance of addressing sources of environmental lead exposure in 
the United States and internationally. 
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1. Introduction  
Medical professionals have long recognized severe lead poisoning as a debilitating disease. Since 
the late 1970s, however, mounting research demonstrates that lead causes irreversible, asymptomatic 
effects at levels far below thresholds previously considered safe. Research suggests that significant 
adverse health effects occur at blood lead levels (BLLs) below the current CDC blood lead action level 
of 10 μg/dL, such as learning and behavioral deficits [1-5] and decreased performance on standardized 
IQ and educational achievement tests [2-10]. Meta-analysis and reviews suggest that there is no 
threshold effect level, and thus any level of exposure is potentially detrimental [11-14]. A number of 
studies demonstrate that significant damage occurs even at blood lead levels below 5 μg/dL [5,9,15].  
Children exposed to lead in utero and in the postnatal period tend to be smaller, weaker, less 
coordinated, and less intelligent than children who have not had significant exposure [2,16-19]. Lead 
exposure during the critical initial neurological development of a fetus may be particularly   
harmful [20]. Prenatal lead exposure has also been associated with criminality [21]. Prenatal exposure 
can occur if the mother is exposed to lead through infrastructure (i.e., lead-based paint), diet, 
cosmetics, or occupational hazards, or if she has lead stores in her body from previous exposure. 
Pregnant women and nursing mothers with high blood lead levels may experience elevations in both 
systolic and diastolic blood pressure [22,23]. In turn, elevated maternal blood pressure during 
pregnancy has been linked to adverse maternal health, as well as slowed and perturbed fetal 
development [24,25].  
Blood lead levels in women of child-bearing age have been decreasing over the previous decades, 
but remain a concern. NHANES data from 1999 to 2002 suggest that women aged 20–59 nationally 
have a mean level of 1.2 μg/dL and 0.3% of women have blood lead levels above 10 μg/dL [26]. The 
rate is slightly lower for all females between age 6 and 19, at 0.2% with BLLs above 10 μg/dL and a 
mean BLL of 1.0 μg/dL. Non-Hispanic black women aged 20–59 have a significantly higher mean 
level of 1.4 μg/dL [26]. Other demographic predictors are consistent with those for children’s BLLs, 
including education, income, age of housing, as well as smoking, alcohol consumption, and living in 
an urban area [27].  
Relatively little is known about blood lead levels in pregnant women. Rothenberg et al. examined 
the pattern of blood lead levels over the course of a pregnancy among 105 women residing in   
Mexico [28]. The authors documented a significant decrease in blood lead levels from week 12 to 
week 20, which they attribute to hemodilution and organ growth [28]. After 20 weeks, however, blood 
lead levels rose again, peaking at parturition. Similarly, Hertz-Piccioto et al. performed a nested cohort 
study of pregnant women in Pittsburgh, PA to examine the pattern of maternal BLLs over the course of 
gestation [29]. They identified the same distinct U-shaped pattern in BLLs as was found in the 
Rothenberg et al. study. Furthermore, they determined that older mothers had a steeper increase in 
BLLs during the latter half of pregnancy than did younger mothers, which was modified by calcium 
intake. Indeed, calcium supplementation may be a cost effective way to reduce maternal blood lead 
levels and thus fetal exposure [30]. The U-shaped pattern of blood lead remains despite 
supplementation, and Lamadrid-Figueroa et al. suggest that exposure is underestimated when plasma 
lead levels are not considered [31].  Int. J. Environ. Res. Public Health 2010, 7          
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Positive findings of blood lead among pregnant women may be indicative of contemporaneous 
exposure to lead or may result from remobilization of lead from bone stores due to either the aging 
process or the physiological stress of pregnancy. This paper has two purposes: first, to document the 
blood lead burdens among a cohort of pregnant women in Durham County, NC; and second, to model 
predictors of blood lead level, with a particular emphasis on disentangling current versus historic 
exposures. The results of the analysis are directly relevant to state, national, and international lead 
policies, as well as the aggressiveness with which the policies should be pursued. 
2. Data and Methods 
The Healthy Pregnancy, Healthy Baby study is an ongoing prospective cohort study of the effects 
of environmental, social, and host factors on racial disparities in pregnancy outcomes. Duke University 
Medical Center (DUMC) Institutional Review Board approval was obtained to enroll pregnant women 
from the Duke Obstetrics Clinic and the Durham County Health Department Prenatal Clinic. Women 
were excluded from participation if they were less than 18 years of age, were not English-literate, were 
greater than 28 weeks’ gestation at study enrollment, lived outside of Durham County, had a   
multi-fetal gestation, had a known fetal genetic or congenital abnormality, or were planning not to 
deliver at DUMC. Demographic, health behavior, and medical history data were obtained by direct 
patient interview at the time of enrollment and through electronic medical record review. Participants 
recruited from June 2005 to December 2008 are included in this analysis. Of the 1505 women 
approached for participation in the study, 1294 consented (86%). At the time of this analysis, we had 
lead levels available for 927 of the enrolled and consented women.  
All participants were geocoded to the individual tax parcel unit based on the residential address 
reported at time of enrollment (96.7% georeferenced). Such highly resolved spatial referencing of the 
data allowed each participant to be linked with parcel level data on age of housing and lead exposure 
risk level. The age of housing (year built) for each parcel was provided by the Durham County Tax 
Assessor. Each tax parcel’s lead exposure risk level was calculated using a model of lead risk that has 
been validated by collection of environmental samples in homes in Durham County. Using tax 
assessor, lead screening, and U.S. Census data, a modeled lead exposure risk estimate for each 
residential tax parcel was calculated by weighting risk factors for lead exposure, including age of 
housing, Census blockgroup median income, and Census blockgroup percent African American 
(detailed methods described previously in [32,33]).  
Maternal blood lead levels were measured in blood samples collected at the time of admission to 
the DUMC Birthing Center for delivery. Whole blood, collected in a trace-metal free vacutainer tube, 
was sent to the Mayo Medical Laboratories for graphic furnace atomic absorption spectrometry for 
determination of BLLs, with a lower limit of detection of 1.0 μg/dL [34]. 
Descriptive statistics were calculated to provide a sense of the cohort under study in terms of both 
demographic data and lead exposure. The population for this analysis was restricted to non-Hispanic 
white, non-Hispanic black, and Hispanic participants who completed the study and had a valid lead 
result available. As only 10.4% of women in our study had blood lead levels greater than 1 µg/dL, we 
categorized blood lead into three ordered groups: below the detection limit, 1 µg/dL, and ≥2 µg/dL. 
We then used cumulative logit models with a proportional odds assumption to assess the relationship Int. J. Environ. Res. Public Health 2010, 7          
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between maternal risk factors and higher lead levels. The proportional odds assumption implies that 
the covariate effects are the same across logits and was tested via a score test. The score tests on all 
three models that we estimate support the validity of the proportional odds assumption. We report the 
results in terms of adjusted odds ratios, confidence intervals, and p-values. Because these analyses 
were exploratory in nature, tests of statistical significance did not include an alpha adjustment. All 
analyses were undertaken using SAS 9.2 (Cary, NC). 
3. Results 
Of the 1294 participants screened and enrolled between June 2005 and December 2008, 6.5% were 
lost to follow-up and 2.2% withdrew. Lead results were only available for participants completing the 
study because blood is collected for lead analysis at delivery rather than enrollment. Lead results were 
available for 927 participants at the time of this study. In addition, only non-Hispanic white,   
non-Hispanic black, and Hispanic participants were included in the analyses presented here. Under 
these restrictions, data on 864 participants were used in the overall analysis. Although almost 97% of 
participants were geocoded, age of housing data was available for 770 of these participants and 
modeled lead exposure risk was available for 701 of these participants.  
Table 1 provides demographic characteristics of the study population for each subset. The 
demographic composition of the each subsets used for the models with a measure of current lead 
exposure (last two columns of Table 1) were not statistically different from the demographic 
composition of the participants in the basic model (p > 0.05 for χ
2 tests of each categorical 
demographic variable; p > 0.05 for t-tests for differences in mean parity). Non-Hispanic black women 
account for almost three-fourths (72.6% in basic model) of the study population (oversampling 
intentional), and roughly two-thirds (65% in the basic model) of participants were under 30 years old. 
Parity measures the total number of deliveries to the mother, including previous term births, previous 
preterm births, and the current delivery. From both national and North Carolina birth data, we know 
that rates of tobacco use during pregnancy are typically highest among non-Hispanic white women and 
lowest among Hispanic women [35,36]. Our study population does not follow this typical pattern, with 
tobacco use rates highest among non-Hispanic black participants (data not shown here).  
Table 1. Demographic distribution of observations in each model. 
 
Basic model  Basic model + age of 
housing 
Basic model + modeled 
exposure risk 
n  %  n %  n % 
Race 
Non-Hispanic  white  179 20.7%  159 20.7%  130 18.5% 
Non-Hispanic  black  627 72.6%  563 73.1%  525 74.9% 
Hispanic  58 6.7%  48 6.2%  46 6.6% 
Age (yrs) 
18–19  70 8.1%  61 7.9%  57 8.1% 
20–24  301 34.8%  268 34.8%  251 35.8% 
25–29  191 22.1%  170 22.1%  159 22.7% Int. J. Environ. Res. Public Health 2010, 7          
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Table 1. Cont. 
30–34  166 19.2%  148 19.2%  132 18.8% 
35–39  107 12.4%  97 12.6%  81 11.6% 
40–44  29 3.4%  26 3.4%  21 3.0% 
Education 
Less than high school  111  12.9%  97  12.6%  91  13.0% 
Parity 
Mean 2.14  2.17  2.16 
SD 1.27  1.29  1.25 
Tobacco use  150 17.4%  128 16.6%  117 16.7% 
Blood lead level 
< 1 µg/dL  663  76.7%  583  75.7%  531  75.8% 
1  µg/dL  112 13.0%  105 13.6%  95 13.6% 
≥ 2 µg/dL  89  10.3%  82  10.7%  75  10.7% 
 
Figure 1 displays the race-specific distributions of blood lead levels among the 864 women included 
in the basic model. As expected, the non-Hispanic white women in our sample generally had lower 
blood lead levels than non-Hispanic black and Hispanic women. In our study, Hispanic women had the 
highest blood lead levels, with 16% having ≥ 2 µg/dL compared to 6% among non-Hispanic white and 
11% among non-Hispanic black women. Almost half of the Hispanic participants in our sample were 
not born in the United States, so maternal lead levels for these women may be related to non-US 
exposures to lead. 
Figure 1. Blood lead levels by race. 
 Int. J. Environ. Res. Public Health 2010, 7          
 
 
1513
As shown in Table 1 and Figure 1, both overall and within each race, the vast majority of 
participants had blood lead levels below the detection limit of 1 µg/dL. Only 2 participants had a blood 
lead level of 5 µg/dL or higher. Due to this sparseness, lead levels over 1 µg/dL were collapsed into a 
single category, and blood lead levels were modeled as three ordered categories of <1 µg/dL, 1 µg/dL, 
and ≥2 µg/dL.  
Three cumulative logit models for the ordered lead level categories were fit: (1) the basic model 
including race, age, education, parity, and tobacco use during pregnancy; (2) the basic model 
covariates plus age of housing; and (3) the basic model covariates plus modeled lead exposure risk. 
The categories of non-Hispanic white and 25–29 years of age served as reference groups. The score 
tests in all three models supported the assumption of proportional odds (score test χ
2 = 5.39, p = 0.86 
for basic model; χ
2 = 4.97, p = 0.93 for age of housing model; and χ
2 = 6.14, p = 0.86 for modeled 
exposure risk model), indicating that the cumulative logit models could be appropriately applied in this 
case. 
Table 2 presents the results for each model. The adjusted odds ratios (aORs) presented in this table 
indicate the probability of having a higher blood lead level compared to the associated reference 
group. In all three models, race, age, and educational attainment were significantly associated with 
blood lead level (p < 0.05). Tobacco use during pregnancy was also significant in the basic and age of 
housing models (p < 0.05; p = 0.07 in the modeled exposure risk model). Non-Hispanic black and 
Hispanic race were significantly associated with increased blood lead level compared to non-Hispanic 
white race (aOR, basic model = 2.90 and 4.92; aOR, age of housing model = 3.49 and 4.54; and aOR, 
modeled exposure risk model = 3.11 and 3.84, respectively; all p < 0.05). Having less than a high 
school education and using tobacco during pregnancy were also associated with higher blood lead 
levels in each model (p < 0.05 in basic and age of housing models). Parity was not significantly 
associated with blood lead level in any of the models, but the adjusted odds ratios on parity were in the 
direction we would expect; i.e., women with previous pregnancies have lower blood lead levels, 
potentially indicating that maternal lead body burdens may have been at least partially off-loaded 
during  the  
earlier pregnancies. 
Table 2. Adjusted odds ratios and 95% confidence intervals for blood lead levels in 
cumulative logit models. 
Basic model (n = 864) 
Basic model + age of housing 
(n = 770) 
Basic model + modeled 
exposure risk (n = 701) 
aOR (95% CI)  P-value  aOR (95% CI)  P-value  aOR (95% CI)  P-value 
Race          
Non-Hispanic white  1.0 — —  1.0  — — 1.0  — — 
Non-Hispanic black  2.90 (1.79–4.70)  < 0.001  3.49 (2.09–5.85)  < 0.001  3.11 (1.75–5.52)  0.002 
Hispanic  4.92 (2.39–10.09)  < 0.001  4.54 (2.04–10.13)  < 0.001  3.84 (1.65–8.89)  < 0.001 
Age (yrs)           
18–19  0.60 (0.28–1.27)  0.179  0.57 (0.26–1.25) 0.160 0.65  (0.29–1.47)  0.296 
20–24  0.54 (0.33–0.89)  0.015  0.51 (0.31–0.87) 0.012 0.60  (0.35–1.02)  0.058 
25–29 1.0  — —  1.0  — — 1.0  — — 
30–34  2.39 (1.47–3.91)  < 0.001  2.47 (1.48–4.12)  < 0.001  2.50 (1.46–4.25)  < 0.001 Int. J. Environ. Res. Public Health 2010, 7          
 
 
1514
35–39  2.98 (1.71–5.18)  < 0.001  3.32 (1.85–5.96)  < 0.001  3.25 (1.74–6.09)  < 0.001 Int. J. Environ. Res. Public Health 2010, 7          
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Table 2. Cont. 
40–44  7.69 (3.49–16.93)  < 0.001  6.27 (2.71–14.55)  < 0.001  6.83 (2.72–17.11)  < 0.001 
Education           
Less than high school  2.17 (1.34–3.51)  0.002  1.99 (1.19–3.31)  0.008  2.07 (1.22–3.49)  0.007 
Parity  0.90 (0.78–1.03)  0.118  0.863 (0.75–0.99) 0.045  0.91  (0.78–1.07) 0.265 
Tobacco use  1.64 (1.07–2.50)  0.022  1.70 (1.08–2.66) 0.021 1.54  (0.96–2.48)  0.073 
Exposure measures            
Age of housing (year built)      0.99 (0.98–1.00)  0.249     
Modeled lead exposure risk          0.99 (0.29–3.40)  0.986 
 
The probability of having a higher blood lead level significantly increased with age. In the basic 
model, compared to the referent of 25–29 years, participants aged 18-19 had an aOR of 0.60   
(95% CI = 0.28, 1.27), those aged 20–24 years an aOR of 0.54 (95% CI = 0.33, 0.89), those aged  
30–34 years an aOR of 2.39 (95% CI = 1.47, 3.91), those aged 35–39 years an aOR of 2.98   
(95% CI = 1.71, 5.18), and those aged 40–44 years an aOR of 7.69 (95% CI = 3.49, 16.93). A similar 
pattern by age was found in both models that included a measure of current lead exposure; although in 
the third model which added modeled lead exposure risk, the 20–24 years age category was not 
significantly different (p = 0.058) from the 25–29 years referent group. Note, however, that age of 
housing was not significant in the second model and modeled lead exposure risk was not significant in 
the third model. Note also that the confidence intervals are wide in some cases due to low sample 
sizes. 
In addition, we checked the sensitivity of the results to both outliers and the classification of blood 
lead level. The two participants with blood lead levels >5 µg/dL, who were originally included in all 
three models, were removed from the dataset and the set of cumulative logit models rerun. Removing 
these outliers did not influence the results or their interpretation. Fitting the three models as simple 
logistic models with blood lead levels dichotomized as detectable/non-detectable (<1 µg/dL   
and ≥1 µg/dL) also did not affect the results. All standard covariates followed similar patterns, both in 
terms of direction and statistical significance, as in the corresponding cumulative logit models. Again, 
the two measures of current lead exposure, age of housing and modeled lead exposure risk, were not 
significantly associated with blood lead level. 
4. Discussion 
Maternal blood lead levels can result from either contemporaneous exposure to lead or through the 
remobilization of lead that has been sequestered in mineralized tissue in response to a historic 
exposure. When distributed to mineralized tissue, especially bone, lead is mistaken for calcium and 
used as faulty building blocks [37]. An estimated 95% of adult’s lead burden is in their bones, 
compared to over 70% of child lead stores [38]. Women are considered be at greater risk than men for 
the remobilization, and much literature documents the significant disparity in the large lead burdens 
rates of blacks [26,39]. 
Research indicates that bone is a living organ that accumulates lead in three compartments with 
three different half-lives and continually remobilizes lead to the bloodstream and other organs. The 
first compartment, periosteum, resembles soft tissue and is very common in growing infants. Int. J. Environ. Res. Public Health 2010, 7          
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Periosteum readily releases lead stores into the bloodstream [38]. A second compartment is the spongy 
or trabecular bone (found in the pelvis, ribs, and skull) with a half-life of 3–5 years. The third 
compartment is cortical bone (midtibia and midfemur) and has the longest resident time with a half-life 
of about 30 years [40]. 
Maternal blood lead levels are inextricably tied to biological processes associated with calcium 
needs, absorption, and desorption. Pregnancy clearly induces a demand for calcium within the fetal 
compartment. Maternal responses to meet this demand can occur through increased absorption of 
calcium in the intestinal tract, changes in calcium conservation via kidney function, or calcium 
desorption from bone [41]. If lead has been absorbed into bone, then a remobilization process may be 
induced by pregnancy itself, due to the demand for calcium within the fetal compartment. 
Maternal blood lead levels may be related to the aging process as well. Peak bone mass is generally 
considered to be achieved in young adulthood [42]. After bone mass peaks, bone loss begins, with 
resorption greater than formation [42]. Again, if lead has been used as a faulty building block in place 
of calcium, then we would expect blood lead levels to increase as women age. In our analysis, 
maternal age was strongly associated with blood lead levels, with younger women having a reduced 
risk and older women having an elevated risk. This result may be indicative of the resorption of bone 
lead in pregnancy. It may also be related to the fact that, due to the temporal patterns of lead exposure, 
older mothers (compared to younger mothers) may have been exposed to more lead on average during 
their childhoods. Other research has suggested a strong connection between bone lead and health 
outcomes potentially arising from exposure. In one study, bone lead predictions had more significant 
associations with hypertension than blood lead [43]. 
This study is limited to women from one county in North Carolina in a study population that 
intentionally oversamples non-Hispanic black women. As such, it should be replicated in other study 
populations to confirm the results found here. In addition, we are unable to incorporate direct measures 
of bone turnover, nutritional intake, or genetic vulnerabilities, all of which may contribute to blood 
lead levels among pregnant women. Nevertheless, we feel that the results presented here constitute an 
important contribution to the literature on lead levels during pregnancy. 
Maternal blood lead levels may also be related to current exposures. In our analyses, however, 
neither measure of current lead exposure (age of housing and modeled lead exposure risk) was 
significantly associated with blood lead levels. The aOR for age of housing was 1.00 (95% CI = 0.99, 
1.01) and for modeled lead exposure risk was 0.88 (95% CI = 0.18, 4.29). Taken in combination with 
the results on maternal age, this finding indicates that maternal blood lead levels are much more likely 
the result of lead remobilization from historic exposures as opposed to contemporaneous exposures. 
5. Conclusions 
The 2005–2006 National Health and Nutrition Examination Survey (NHANES) data reveal blood 
lead levels elevated above the CDC action level of 10 μg/dL in 1.3 percent of one to five year olds in 
the United States, with children tested having an overall geometric mean blood lead level of   
1.7 μg/dL [44]. These data indicate that over 500,000 children under age six currently experience 
blood lead levels above the CDC blood lead action level [45]. Given the recent research on health Int. J. Environ. Res. Public Health 2010, 7          
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effects of low level lead exposure, roughly 37% of children aged one to five in the United States are 
estimated to have blood lead levels greater than or equal to 2 μg/dL [44]. 
The results from this analysis indicate that pregnant women themselves (and adults more generally) 
are likely serving as a reservoir for lead stores. These stores are remobilized to the blood stream 
through natural aging processes, and rates of remobilization are likely accelerated by the physiological 
stress and calcium homeostasis of pregnancy. Lead diffuses from the mother’s bloodstream to the fetus 
across the placenta and accumulates in fetal organs. From a public health perspective, this means that 
even if all lead sources were abated immediately and completely, women and their growing fetuses 
would remain at risk for lead exposure for decades. Yet a significant number of US children today still 
carry unacceptable blood lead levels. These numbers are even higher globally when considering the 
several countries that have limited or no restrictions on lead in gasoline and industry. Thus, this work 
again emphasizes the critical importance of aggressively addressing sources of environmental lead 
exposure both in the United States and internationally. 
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